Evidence map›Paper›PMID 30306735›Full record

ArticleAnatomical record (Hoboken, N.J. : 2007)2019

Endothelial Cell Lineage Analysis Does Not Provide Evidence for EMT in Adult Valve Homeostasis and Disease.

Andrew J Kim, Christina M Alfieri, Katherine E Yutzey

Open access · bronzeAbstract read
In one paragraph

Article in Anatomical record (Hoboken, N.J. : 2007), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Lineage Tracing Identifies Dynamic Contribution of Endothelial Cells to Cardiac Valve Mesenchyme During Development.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2023
    Article
  4. Article
  5. Protective Role of Endothelial Fibulin-4 in Valvulo-Arterial Integrity.Journal of the American Heart Association · 2023
    Article
  6. Article
  7. Genetics and pathophysiology of mitral valve prolapse.Frontiers in cardiovascular medicine · 2023
    Review
  8. Endothelial-Mesenchymal Transition in Cardiovascular Disease.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Biology and Biomechanics of the Heart Valve Extracellular Matrix.Journal of cardiovascular development and disease · 2020
    Review
  13. The Endocardium and Heart Valves.Cold Spring Harbor perspectives in biology · 2020
    Review
  14. Article
  15. Article
  16. Endothelial-to-Mesenchymal Transition.Circulation research · 2019
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew J KimThe Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.ORCID 0000-0002-4923-6343
Christina M AlfieriThe Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Katherine E YutzeyORCID 0000-0002-1444-7124
Cincinnati Children's Hospital Medical Center · US

Funding

Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
Twist1 regulation of valve progenitorsR01HL082716 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI YUTZEY, KATHERINE E · 2006 to 2014
$3.3M
Wnt signaling in heart valve development and diseaseR01HL094319 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI YUTZEY, KATHERINE E · 2009 to 2015
$2.4M
Mechanisms of Congenital Heart Valve DiseaseR01HL143881 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI YUTZEY, KATHERINE E · 2018 to 2021
$1.9M
Cell Signaling Mechanisms of Calcific Aortic Valve DiseaseR01HL114682 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI YUTZEY, KATHERINE E · 2012 to 2015
$1.5M
American Heart Association 16PRE30180000NHLBI NIH HHS R01 HL082716NHLBI NIH HHS R01 HL094319NHLBI NIH HHS R01 HL114682NHLBI NIH HHS R01 HL143881NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

Epithelial-to-mesenchymal transition (EMT) enables stationary epithelial cells to exhibit migratory behavior and is the key step that initiates heart valve development. Recent studies suggest that EMT is reactivated in the pathogenesis of myxomatous valve disease (MVD), a condition that involves the progressive degeneration and thickening of valve leaflets. These studies have been limited to in vitro experimentation and reliance on histologic costaining of epithelial and mesenchymal markers as evidence of EMT in mouse and sheep models of valve disease. However, longitudinal analysis of cell lineage origins and potential pathogenic or reparative contributions of newly generated mesenchymal cells have not been reported previously. In this study, a genetic lineage tracing strategy was pursued by irreversibly labeling valve endothelial cells in the Osteogenesis imperfecta and Marfan syndrome mouse models to determine whether they undergo EMT during valve disease. Tie2-CreER

Indexed as

Cell LineageDisease Models, AnimalGene Expression Regulation, DevelopmentalAdipokinesAnimalsCollagen Type IEndothelium, VascularEpithelial-Mesenchymal TransitionFemaleFibrillin-1Heart ValvesHomeostasisMaleMarfan SyndromeMiceMice, KnockoutAdipokinesCol1a2 protein, mouseCollagen Type IFbn1 protein, mouseFibrillin-1EMTepithelial-to-mesenchymal transitionheart valveshematopoietic cellsMarfan syndromemyxomatous degenerationosteogenesis imperfectavalve disease

Identifiers

PMID30306735
PMCPMC6312497
OpenAlexW2896964113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.